The products include high-quality, advanced anti-infective formulations such as EMROK (Levonadifloxacin) and MIQNAF (Nafithromycin)
Transformation to increase speed and redirect resources to growth opportunities within diabetes and obesity, aiming at reaching millions of untreated patients
The Ma’anshan site approval covers pastilles, oral liquids, and powders
This year’s edition will witness participation of over 700 Indian exporters showcasing their products and services; 500+ overseas delegates representing more than 120 countries; 20,000 domestic visitors; and 8,000+ B2B meetings
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Reinforcing commitment to ethical and sustainable growth
Revenue from operations rose 14.8 per cent year-on-year to Rs. 3,942 crore
The savings will be fully reinvested to support new product launches and its pipeline across multiple therapeutic areas
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
The coating is designed for heat-sealable applications, offering oil and grease resistance on kraft paper and suitable blister coatings for paper and paperboard
Subscribe To Our Newsletter & Stay Updated
